Cargando…
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
Cancer has become a global health problem, accounting for one out of six deaths. Despite the recent advances in cancer therapy, there is still an ever-growing need for readily accessible new therapies. The process of drug discovery and development is arduous and takes many years, and while it is ong...
Autores principales: | Ma, Zhaowu, Woon, Clariis Yi-Ning, Liu, Chen-Guang, Cheng, Jun-Ting, You, Mingliang, Sethi, Gautam, Wong, Andrea Li-Ann, Ho, Paul Chi-Lui, Zhang, Daping, Ong, Peishi, Wang, Lingzhi, Goh, Boon-Cher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758560/ https://www.ncbi.nlm.nih.gov/pubmed/35035355 http://dx.doi.org/10.3389/fphar.2021.828856 |
Ejemplares similares
-
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials
por: Yu, Jiahui, et al.
Publicado: (2023) -
Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021) -
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy
por: Li, Juan, et al.
Publicado: (2022) -
Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022) -
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development
por: Wang, Lingzhi, et al.
Publicado: (2016)